Safe Family

Safe Family: Miss South Texas


Safe Family: Safe Drinks


Safe Family: Knee Replacements


FDA proposes first regulations for e-cigarettes


Safe Family: App developed to help out in case of school shooting


Safe Family: Kids and Water


Safe Family: Midsize SUVs


Study finds many preteens have high cholesterol


Local father following trend and staying home


Safe Family: BB gun problems


Load More Stories
 

CBS News Health Headlines

A new study looks at the consequences of moving bedtimes or letting babies cry it out
As mosquito season begins, experts look to lessons learned from the successful fight against dengue in these Florida suburbs
Going on a clear-liquid diet the day before a colonoscopy has some drawbacks, and a new study suggests it may not be necessary
Some 50 years ago, roughly 42 percent of U.S. adults smoked, but picture is radically different today

WebMD Health News

Two long-recommended methods seem effective and bring no psychological harm, study finds

Researchers suspect low levels of spexin might play contributing role

Consuming limited amount of low-fiber food day before didn't disrupt procedure, study finds

Study raises provocative questions, expert says

Eased symptoms, healed colons in 1 in 4 patients

AP Top Health Stories

Both sleep-training programs were linked to better sleep for babies, but parent education wasn’t, researchers report in Pediatrics. “Parents often have a misconception of a baby’s sleep patterns and they think that babies will sleep through the night much earlier in life than they are ready to physiologically,” Goodstein, who wasn’t involved in the study, added by email.

Monsanto is displayed on a screen where the stock is traded on the floor of the NYSEMonsanto Co , the world's largest seed company, will reject Bayer AG's $62 billion acquisition bid and seek a higher price, two people familiar with the matter said on Tuesday. Monsanto can see the logic of combining with the German drugs and crop chemicals group, and believes a deal could get the necessary antitrust and other regulatory approvals, the people said, leaving the door open for further negotiations. Bayer will now have to decide whether to raise its bid, even as the company faces criticism from some shareholders that its $122-per-share offer is already too high.


A person receives a test for diabetes during Care Harbor LA free medical clinic in Los AngelesBy Kate Kelland LONDON (Reuters) - People with diabetes should be offered gastric surgery as a standard treatment option which could help control it for years without medication, the world's leading diabetes groups said. A joint statement from a 45-strong group said on Tuesday that bariatric, or metabolic, surgery could have a significant benefit for hundreds of thousands of patients worldwide, which they said represented one of the biggest shifts in diabetes treatment guidelines since the advent of insulin. The new guidelines say surgery to reduce the stomach and induce weight loss should be recommended to treat all diabetes patients whose body mass index (BMI) is 40 or over, regardless of their blood glucose control, as well as those with a BMI of 30 and over whose blood sugar levels are not being controlled by lifestyle changes or medication.


FILE - In this May 8, 2014 file photo, an overweight is seen in New York. International diabetes organizations are calling for weight-loss surgery to become a more routine treatment option for diabetes, even for some patients who are only mildly obese. Obesity and Type 2 diabetes are a deadly pair, and numerous studies show stomach-shrinking operations can dramatically improve diabetes. (AP Photo/Mark Lennihan, File)WASHINGTON (AP) — International diabetes organizations are calling for weight-loss surgery to become a more routine treatment option for diabetes, even for some patients who are only mildly obese.


The office building of health insurer Anthem in seen in Los Angeles, CaliforniaBy Caroline Humer NEW YORK (Reuters) - Anthem Inc Chief Executive Officer Joseph Swedish said on Tuesday the health insurer was pushing for approval from antitrust regulators reviewing its $51 billion acquisition of Cigna Corp and expects to hear a decision in July. Anthem's bid for Cigna followed closely after Aetna Inc's proposed $34 billion purchase of Humana Inc last July. Swedish said antitrust regulators have asked many questions about how it and Cigna manage healthcare benefits for large employers, but that the overall review was moving forward as expected.